Quarterly Newsletter
Sign-up to receive Innovation's quarterly newsletter

Privacy by Exact Target

Committed to Medical Innovations

Every day - in research labs across eastern Massachusetts - investigators, doctors and nurses at Partners HealthCare are working to discover new treatment options, medical devices and technology to improve the lives and outcomes of patients. Partners HealthCare Innovation works directly with these researchers to commercialize their innovations. It is our mission to enable commercialization through the best route for a given technology, and ensure that technologies can benefit patients.

Announcement: CTI-JDRF Call for Proposals

Partners HealthCare Innovation and Pfizer’s Centers for Therapeutic Innovation (CTI) are pleased to announce a Partners-wide call for proposals of translational projects involving the development of bio-therapeutics for the treatment of Type 1 diabetes and associated conditions. In partnership with the Juvenile Diabetes Research Foundation (JDRF), CTI will support research in focus areas of immune tolerance, diabetic nephropathy and beta cell health. The pre-proposal submission deadline is Friday, March 14, 2014.Additional information is on the Partners CTI-JDRF page.  The pre-proposal outline can be downloaded here.


Partners HealthCare Innovation and Pfizer’s Centers for Therapeutic Innovation (CTI) are pleased to announce a Partners-wide call for proposals of translational projects involving the development of bio-therapeutics for the treatment of Type 1 diabetes and associated conditions. In partnership with the Juvenile Diabetes Research Foundation (JDRF), CTI will support research in focus areas of immune tolerance, diabetic nephropathy and beta cell health. The pre-proposal submission deadline is Friday, Feb. 14, 2014. The pre-proposal outline can be downloaded here.

December 2013 Newsletter

Partners-ZMAG-131210_1419-FD-THUMB-SM.jpg
View our e-newsletter

About Innovation

Our Mission
Leadership Team
Directions
Contact Us
LinkedIn Group 

Close

2011 Annual Report